目的 为进一步规范平台医疗机构中药饮片临床使用,提高中药饮片疗效.方法 抽取 2021 年平台医疗机构处方共3900 张,通过处方点评后的持续改进措施和建议,抽取改进后2022 年平台医疗机构处方共3900 张进行点评,比较改进措施前后的处方不合理率.结果 2021 年不合理处方共 163 张,处方不合理率为 4.17%;2022 年不合理处方共 50 张,处方不合理率为1.28%,处方不合理率较改进前下降(P<0.05).结论 加强中药饮片处方点评有利于提高平台处方质量,提升平台合理用药水平,保障区域内患者用药的安全经济有效.
Objective In order to further standardize the clinical use of TCM decoction pieces in platform medical institutions and improve the efficacy of TCM decoction pieces.Methods A total of 3900 prescriptions from the platform medical institutions in 2021 were selected for review,and a total of 3900 prescriptions from the platform medical institutions in 2022 were selected for review through the continuous improvement measures and suggestions after prescription review,and the irrational rate of prescriptions before and after the improvement measures were compared.Results There were 163 irrational prescriptions in 2021,and the irrational rate was 4.17%.In 2022,there were 50 irrational prescriptions in total,and the irrational rate of prescriptionswas1.28%,which was lower than that before improvement(P<0.05).Conclusion Strengthening the prescription review of TCM decoction pieces was beneficial to improving the prescription quality of the platform,enhancing the level of rational drug use on the platform,and ensuring the safety,economy and effectiveness of drug use for patients in the region.